SCHEMBL30952928

SCHEMBL30952928

CCc1nonc1C(=O)N[C@H](C(=O)Nc1cc(CN2C[C@@H](C(F)(F)F)NC2=O)ccn1)[C@@H](C)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ IL17A Q16552 5/20 0.41
▸ PYGL P06737 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30953026 0.93 IL17A (0.41) IL17APYGL
SCHEMBL30953067 0.91 IL17A (0.48) IL17APYGL
SCHEMBL30953031 0.91 IL17A (0.48) IL17APYGL
SCHEMBL30953017 0.85 IL17A (0.36) IL17APYGL
SCHEMBL30953027 0.85 IL17A (0.37) IL17APYGL
SCHEMBL30953012 0.85 IL17A (0.38) IL17APYGL
SCHEMBL30953070 0.83 IL17A (0.41) IL17A
SCHEMBL30953265 0.81 CTSL (0.37) —
SCHEMBL30953347 0.81 IGF1R (0.34) IL17A
SCHEMBL30953483 0.81 IGF1R (0.34) IL17A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP claimed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO claimed
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP disclosed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO disclosed
Send feedback